Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment

被引：47

作者：

Terao, Toshiki ^{[1
,2
]}

Minami, Yosuke ^{[1
]}

机构：

[1] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan

[2] Kameda Med Ctr, Dept Internal Med, Div Hematol Oncol, Kamogawa 2968602, Japan

来源：

CELLS | 2019年 / 8卷 / 04期

关键词：

Hedgehog pathway; acute myeloid leukemia; AML; leukemic stem cell; glioma; Smoothened; glasdegib; sonidegib; STEM-CELLS; MYELODYSPLASTIC SYNDROME; GLASDEGIB PF-04449913; CLINICAL-IMPLICATIONS; PHASE IB; GLI; INHIBITOR; MUTATIONS; ACTIVATION; THERAPY;

D O I：

10.3390/cells8040312

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are important for the tumor cells' cycle or therapeutic resistance of AML cells. In this article, we will review the current trends in Hh pathway inhibitors for treating AML.

引用

页数：11

共 66 条

[1] Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor [J].

Akare, Uday Raj ;

Bandaru, Srinivas ;

Shaheen, Uzma ;

Singh, Pramod Kumar ;

Tiwari, Geet ;

Singare, Paramanand ;

Nayarisseri, Anuraj ;

Banerjee, Tushar .

BIOINFORMATION, 2014, 10 (12) :737-742

[2] Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold [J].

Berardozzi, Simone ;

Bernardi, Flavia ;

Infante, Paola ;

Ingallina, Cinzia ;

Toscano, Sara ;

De Paolis, Elisa ;

Alfonsi, Romina ;

Caimano, Miriam ;

Botta, Bruno ;

Mori, Mattia ;

Di Marcotullio, Lucia ;

Ghirga, Francesca .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 :554-562

[3] Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial [J].

Bixby, Dale ;

Noppeney, Richard ;

Lin, Tara L. ;

Cortes, Jorge ;

Krauter, Juergen ;

Yee, Karen ;

Medeiros, Bruno C. ;

Kraemer, Alwin ;

Assouline, Sarit ;

Fiedler, Walter ;

Dimier, Natalie ;

Simmons, Brian P. ;

Riehl, Todd ;

Colburn, Dawn .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (03) :595-598

[4] Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma [J].

Blotta, Simona ;

Jakubikova, Jana ;

Calimeri, Teresa ;

Roccaro, Aldo M. ;

Amodio, Nicola ;

Azab, Abdel Kareem ;

Foresta, Umberto ;

Mitsiades, Constantine S. ;

Rossi, Marco ;

Todoerti, Katia ;

Molica, Stefano ;

Morabito, Fortunato ;

Neri, Antonino ;

Tagliaferri, Piersandro ;

Tassone, Pierfrancesco ;

Anderson, Kenneth C. ;

Munshi, Nikhil C. .

BLOOD, 2012, 120 (25) :5002-5013

[5] Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].

Bonnet, D ;

Dick, JE .

NATURE MEDICINE, 1997, 3 (07) :730-737

[6]

Chakrabarti Jayati, 2018, Oncotarget, V9, P37439, DOI 10.18632/oncotarget.26473

[7] Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia [J].

Chan, Steven M. ;

Majeti, Ravindra .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) :648-657

[8] Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome [J].

Cortes, Jorge E. ;

Heidel, Florian H. ;

Hellmann, Andrzej ;

Fiedler, Walter ;

Smith, B. Douglas ;

Robak, Tadeusz ;

Montesinos, Pau ;

Pollyea, Daniel A. ;

DesJardins, Pierre ;

Ottmann, Oliver ;

Ma, Weidong Wendy ;

Shaik, M. Naveed ;

Laird, A. Douglas ;

Zeremski, Mirjana ;

O'Connell, Ashleigh ;

Chan, Geoffrey ;

Heuser, Michael .

LEUKEMIA, 2019, 33 (02) :379-389

[9] Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results [J].

Cortes, Jorge E. ;

Smith, B. Douglas ;

Wang, Eunice S. ;

Merchant, Akil ;

Oehler, Vivian G. ;

Arellano, Martha ;

DeAngelo, Daniel J. ;

Pollyea, Daniel A. ;

Sekeres, Mikkael A. ;

Robak, Tadeusz ;

Ma, Weidong Wendy ;

Zeremski, Mirjana ;

Shaik, M. Naveed ;

Laird, A. Douglas ;

O'Connell, Ashleigh ;

Chan, Geoffrey ;

Schroeder, Mark A. .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (11) :1301-1310

[10] PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model [J].

Deng, Rui ;

Fan, Fang-yi ;

Yi, Hai ;

Liu, Fang ;

He, Guang-cui ;

Sun, Hao-ping ;

Su, Yi .

HEMATOLOGY, 2018, 23 (10) :740-746

← 1 2 3 4 5 6 7 →